Dive Brief Inspire plans to start a soft launch of the device late in 2024 and move into a full release in 2025. Published Aug. 5, 2024 By Nick Paul TaylorContributor Inspire Medical Systems’ patient app and remote. Courtesy of Inspire Medical Systems Dive Brief:Inspire Medical Systems received Food and Drug Administration approval for its...
by Nathaniel Weixel – 08/08/24 1:51 PM ET COVID-19 killed far fewer Americans in 2023 than 2022, according to provisional data from the Centers for Disease Control and Prevention (CDC). The percentage of people who died from the disease dropped nearly 69 percent last year, and COVID-19 was listed as the 10th leading cause of...
Delirium Improving Symptoms of Chronic Schizophrenia in Elderly: A Case SeriesClinical Medical Reviews and Case Reports Prerak Kumar1*, Shailendra Mohan Tripathi2, Richa Shukla1 and Roshni Basu1 1Senior Resident, Department of Geriatric Mental Health, King George’s Medical University, Lucknow, Uttar Pradesh, India 2Additional Professor, Department of Geriatric Mental Health, King George’s Medical University, Lucknow, Uttar Pradesh,...
August 9, 2024 by Korea University College of Medicine Graphical Abstract. Credit: European Journal of Preventive Cardiology (2024). DOI: 10.1093/eurjpc/zwae061It has been discovered that older adults over 60 years old who are prescribed statins against air pollutant exposure can reduce the risk of cardiovascular disease, especially stroke. By utilizing the National Health Insurance Service big...
August 8, 2024 by Andrew Michael Cooke, The Conversation Credit: Pixabay/CC0 Public DomainThe Olympic and Paralympic Games represent the pinnacle of athletic achievement, where the world’s sporting elite showcase their prowess. Modern athletes benefit from top-notch coaching, optimized nutrition and recovery strategies. Yet, some are turning to more unique methods for the competitive edge—training the...
Price competition’s society-altering test Illustration: Aïda Amer/Axios Two facts about GLP-1s tend to dominate conversations: Their effectiveness is almost too good to be true, and if everyone who could benefit from them received them — at least at current prices — the cost would be prohibitively expensive. Why it matters: With the development pipeline chock-full...
News Release 8-Aug-2024 Peer-Reviewed PublicationBoston University School of Medicine (Boston)—Chronic venous insufficiency (CVI), which impacts more than 25 million people, includes varicose and spider veins. They occur when the veins become damaged and can’t work as they should. Treatments include sclerotherapy, which involves injecting a chemical solution directly into the varicose or spider vein which...
News Release 8-Aug-2024 Peer-Reviewed PublicationUniversity of Virginia Health System image: “We hope this discovery will stimulate further work in the treatment of recurrent wheeze and viral infections in children,” said researcher W. Gerald Teague, MD, a pediatric pulmonologist at UVA Health Children’s and the University of Virginia School of Medicine. “The field has to get...
News Release 8-Aug-2024 Peer-Reviewed PublicationApplied Microbiology International A recent review in the journal Sustainable Microbiology discusses how the use of biocides can promote well-being – but must only be used when there are clear benefits. Biocide use should be restricted to applications where there are tangible benefits but also not unnecessarily restricted where genuine benefits...
News Release 8-Aug-2024 Peer-Reviewed PublicationInstitute for Clinical Evaluative Sciences image: Common antibiotics carry serious riskof life-threatening drug reactions,but safer options exist Credit: ICES Toronto, ON, May 15, 2024 – Two classes of commonly prescribed oral antibiotics are associated with the greatest risk for severe drug rashes that can lead to emergency department visits, hospitalizations and...
